Alan Buchman, MD, MSPH

University of Illinois at Chicago, College of Medicine, Surgery, Faculty Member

Followers

Following

Co-authors

Mentions

Public Views

Dr. Buchman is Director of Gastroenterology at Elevance Health (Formerly Anthem Health) and also Professor of Clinical Surgery at the University of Illinois at Chicago (UIC)/UI Health where he is the Medical Director of the Intestinal Rehabilitation and Transplant Program. Dr Buchman is a former Professor of Medicine and Surgery in the Division of Gastroenterology at the Feinberg School of Medicine, Northwestern University in Chicago where he established their Inflammatory Bowel Disease Center and Intestinal Rehabilitation Centers. He lead the effort for UIC’s Medicare certification for their intestinal transplant center, now one of the largest and most successful in the world.

Dr. Buchman took his undergraduate training at Northwestern University and obtained his medical degree at the Chicago Medical School. After a residency at Cedars Sinai Medical Center in Los Angeles, he completed a fellowship in Clinical Nutrition at UCLA and also received his Master's of Science Degree in Public Health. Following this, Dr. Buchman completed a fellowship in Gastroenterology at Emory University and then served on the faculties of the Baylor College of Medicine and the University of Texas at Houston Medical School prior to moving to Northwestern and subsequently to the University of Illinois at Chicago.

Dr. Buchman has served on 21 peer-reviewed journal editorial boards in such capacities as associate editor and section editor, and has authored nearly 250 peer-reviewed articles, editorials, book chapters and four books. He is currently the editor for the renowned journal Gastroenterology Clinics of North America. Dr. Buchman has been the recipient of numerous national awards from several different societies including the American Gastroenterology Association (The Fitterman Foundation’s Hugh Butt Award in Hepatology and Nutrition), American Society for Nutrition (Physician Nutrition Specialist Award and the Mead Johnson Award), American College of Nutrition (Grace Goldsmith Award), the American Society for Enteral and Parenteral Nutrition (Stanley Dudrick Research Scholar Award), the Southern Medical Society (Seale Harris Award), and the Chicago Medical School Distinguished Alumni Award.

Dr. Buchman, a former president of the American Federation for Medical Research (AFMR) has served on numerous national committees, including the FDA’s Gastrointestinal Drugs Review Committee, where he has served as acting chair, the AGA’s Education and Manpower and Training Committees, the Council of the Central Society for Clinical Research, and the Congressional National Commission on Digestive Diseases. He is a past the chair of the AGA’s Nutrition and Obesity Section. He is the current chair of the Congress of the Intestinal Rehabilitation and Transplant Association (CIRTA).

Dr. Buchman’s research has focused on complications and treatment of inflammatory bowel disease as well as the complications of intestinal failure and long-term parenteral nutrition, and has published seminal manuscripts in these areas. Dr. Buchman is considered a world authority in nutrition, intestinal failure as well as inflammatory bowel disease and has had numerous television, radio, and print media appearances. He consults widely on FDA-related matters, study design for drugs and devices, medicolegal (including patent defense and prosecution, and labeling issues, and is the recipient of numerous patents himself), data interpretation, and advising companies on payer-related issues.
Phone: 3129539984
Address: University of Illinois at Chicago
Department of Surgery
840 S. Wood St. CSB (MC 958)

less

Interests

Uploads

Papers by Alan Buchman, MD, MSPH

The Crisis in Clinical Research: Panel Discussion III

Journal of Investigative Medicine, 2010

Perhaps lunch has had a mellowing effect, but I get a sense of disconnect between this morning's ... more Perhaps lunch has had a mellowing effect, but I get a sense of disconnect between this morning's and this afternoon's talks. This morning, we heard about a major crisis: nothing is getting done and we are losing our clinical researchers to old age, death, and senility. This afternoon, everything is going well primarily because the government is accomplishing a lot. I am a little cynical, but part of my role is to be a curmudgeon. Could we address this disparity? Dr. Buchman: These issues are our concerns, although we have seen improvements in funding, for example, and in some priorities for clinical investigation. We have to look at the Clinical and Translational Science Awards (CTSAs) program, which is replacing some General Clinical Research Centers. We have looked at a CTSA program whose initial sites were funded fully. Since then, those sites were funded at less than 50%. We looked at an educational program that improved but is still not sufficient to train clinical investigators for the present, notwithstanding the future. We have looked at the National Institutes of Health (NIH) budget, which has increased but can often be viewed as a sine wave. With this evidence of crisis in clinical research, how do we encourage people to go into clinical research and retain them if they do not know if there will be future funding, or which end of the sine wave is going to up for them? The risk is a bit like retiring today; we do not know which way the stock market is going to go. Each of these represented agencies is doing great things and yet admits you can improve. Where do you see the problems? And regarding the success of your agencies, where do you stand and what do you need? Dr. Anthony Hayward (National Center for Research Resources, National Institutes of Health): We do see things that we would like to accomplish. Above all, we would like to speed clinical trials and thus speed the progress of medical research. To do that, we need to work together. We need to develop a funding strategy that promotes cooperation and the rising of the best ideas to the surface so that we pursue those ideas. We need also to help people cross the so-called valley of death that Larry addressed so that successful laboratory interventions are actually disseminated out into the community. Also, we live in a competitive world. We are aware that a lot of clinical research is moving to China and India. We would like

Alan Buchman, MD, MSPH

Uploads

Papers by Alan Buchman, MD, MSPH

Log In